NCT06488222 2026-03-11
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
University of Florida
Phase 2 Recruiting
University of Florida
University of Arizona
IDEAYA Biosciences
Mayo Clinic
Hospital Centre Biel/Bienne
Hoosier Cancer Research Network
Zhuhai Beihai Biotech Co., Ltd